Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Receivables (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Receivables for 3 consecutive years, with $12.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables fell 30.03% year-over-year to $12.0 million, compared with a TTM value of $12.0 million through Sep 2025, down 30.03%, and an annual FY2024 reading of $11.9 million, up 9.8% over the prior year.
  • Receivables was $12.0 million for Q3 2025 at SBC Medical Group Holdings, up from $10.9 million in the prior quarter.
  • Across five years, Receivables topped out at $17.2 million in Q3 2024 and bottomed at $10.4 million in Q1 2025.
  • Average Receivables over 3 years is $12.2 million, with a median of $11.4 million recorded in 2024.
  • The sharpest move saw Receivables increased 9.8% in 2024, then crashed 30.03% in 2025.
  • Year by year, Receivables stood at $10.9 million in 2023, then increased by 9.8% to $11.9 million in 2024, then grew by 0.8% to $12.0 million in 2025.
  • Business Quant data shows Receivables for SBC at $12.0 million in Q3 2025, $10.9 million in Q2 2025, and $10.4 million in Q1 2025.